Intervacc

During 2009 further vaccine trials have been finalised and analysed with positive results. We have in these tests reduced the fusion proteins from seven to three. This indicates that the production costs can be greatly reduced.
Read more...

Vaccination is a growing cornerstone in the control and prophylaxis of severe contagious diseases in both man and animals.
Read more

Intervacc is a biotech company in the absolute research front in the development of efficacious and safe vaccines within the animal health area.
Read more

Swedish Television about the new vaccine that gives hope >>